Dr. Ciaran Browne:

It is up to 6,000. Do not forget that if we get additional stocks in, we will use the intradermal application. That allows for an expansion of the actual number of vials into a larger cohort of the population. We hope that if we get those additional stocks, we could be vaccinating up to 6,000 people.